Evaluation of IL-6 in Synovial Fluid in Obese and Normal Weight Patients Suffering From Gonarthrosis During PTA
NCT ID: NCT05145504
Last Updated: 2023-08-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
37 participants
OBSERVATIONAL
2021-11-18
2023-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Correlation Between Altered Glycometabolic Status and Joint Inflammation in Diabetic Patients With Osteoarthritis Undergoing Knee Arthroplasty
NCT05150119
Adipose Tissue and Symptomatic Gonarthrosis
NCT06314191
Diagnostic Value of a Biomarker of Non-surgical Knee Osteoarthritis
NCT04324554
Microfluidic Organotypic Model for Monocyte Transendothelial Migration to the Joint in Obese Osteoarthritic Patients
NCT03347500
Analyzing Composition and Lubrication Properties of Synovial Fluid
NCT00912106
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
20 obese patients, with BMI ≥ 30
Evaluation of IL-6 biomarkers in synovial fluid
Evaluation of IL-6 biomarkers in synovial fluid in obese and normal weight patients with gonarthrosis
20 normal weight patients with BMI between 18.5 - 24.9 inclusive
Evaluation of IL-6 biomarkers in synovial fluid
Evaluation of IL-6 biomarkers in synovial fluid in obese and normal weight patients with gonarthrosis
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Evaluation of IL-6 biomarkers in synovial fluid
Evaluation of IL-6 biomarkers in synovial fluid in obese and normal weight patients with gonarthrosis
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Normal weight patients with BMI 18-24.9 included
* Obese patients with BMI ≥ 30
* Patients suffering from gonarthrosis awaiting knee arthroplasty surgery
* Patients awaiting knee replacement surgery
* Patients who agree to sign informed consent
Exclusion Criteria
* Patients over 85 years of age
* Patients suffering from diabetes mellitus
* Patients who are unable to understand
* Patients with severe neurological disorders or severe disability
* Rheumatoid arthritis patients
* Cancer patients
* Patients on immunosuppressive therapy
55 Years
85 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
IRCCS Istituto Ortopedico Galeazzi
Milan, , Italy
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IL6PG
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.